Literature DB >> 25670861

MicroRNA-873 (miRNA-873) inhibits glioblastoma tumorigenesis and metastasis by suppressing the expression of IGF2BP1.

Ren-jie Wang1, Jian-wei Li2, Bu-he Bao1, Huan-cheng Wu2, Zhen-hua Du1, Jing-liang Su2, Ming-hua Zhang1, Hai-qian Liang3.   

Abstract

Glioblastoma multiforme (GBM) is known as a highly malignant brain tumor with a poor prognosis, despite intensive research and clinical efforts. In this study, we observed that microRNA-873 (miR-873) was expressed at low levels in GBM and that the overexpression of miR-873 dramatically reduced the cell proliferation, migration, and invasion of GBM cells. Our further investigations of the inhibition mechanism indicated that miR-873 negatively affected the carcinogenesis and metastasis of GBM by down-regulating the expression of IGF2BP1, which stabilizes the mRNA transcripts of its target genes. These results demonstrate that miR-873 may constitute a potential target for GBM therapy.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  GBM; Gene Expression; Glioblastoma; IGF2BP1; Insulin-like Growth Factor (IGF); MicroRNA (miRNA); MicroRNA Mechanism; MicroRNA miR-873

Mesh:

Substances:

Year:  2015        PMID: 25670861      PMCID: PMC4423684          DOI: 10.1074/jbc.M114.624700

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status.

Authors:  Xuan Zhou; Yu Ren; Lynette Moore; Mei Mei; Yongping You; Peng Xu; Baoli Wang; Guangxiu Wang; Zhifan Jia; Peiyu Pu; Wei Zhang; Chunsheng Kang
Journal:  Lab Invest       Date:  2010-01-04       Impact factor: 5.662

2.  Overexpressed miRNA-137 inhibits human glioma cells growth by targeting Rac1.

Authors:  Guan Sun; Ying Cao; Lei Shi; Lihua Sun; Yingyi Wang; Chen Chen; Zhengqiang Wan; Linshan Fu; Yongping You
Journal:  Cancer Biother Radiopharm       Date:  2013-05       Impact factor: 3.099

3.  Evidence for rearrangement, amplification, and expression of c-myc in a human glioblastoma.

Authors:  J Trent; P Meltzer; M Rosenblum; G Harsh; K Kinzler; R Mashal; A Feinberg; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

4.  Extensive modulation of a set of microRNAs in primary glioblastoma.

Authors:  S A Ciafrè; S Galardi; A Mangiola; M Ferracin; C-G Liu; G Sabatino; M Negrini; G Maira; C M Croce; M G Farace
Journal:  Biochem Biophys Res Commun       Date:  2005-09-09       Impact factor: 3.575

Review 5.  Malignant astrocytic glioma: genetics, biology, and paths to treatment.

Authors:  Frank B Furnari; Tim Fenton; Robert M Bachoo; Akitake Mukasa; Jayne M Stommel; Alexander Stegh; William C Hahn; Keith L Ligon; David N Louis; Cameron Brennan; Lynda Chin; Ronald A DePinho; Webster K Cavenee
Journal:  Genes Dev       Date:  2007-11-01       Impact factor: 11.361

6.  Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal.

Authors:  Jakub Godlewski; Michal O Nowicki; Agnieszka Bronisz; Shanté Williams; Akihiro Otsuki; Gerard Nuovo; Abhik Raychaudhury; Herbert B Newton; E Antonio Chiocca; Sean Lawler
Journal:  Cancer Res       Date:  2008-11-15       Impact factor: 12.701

7.  Expression of the RNA-binding protein IMP1 correlates with poor prognosis in ovarian carcinoma.

Authors:  M Köbel; D Weidensdorfer; C Reinke; M Lederer; W D Schmitt; K Zeng; C Thomssen; S Hauptmann; S Hüttelmaier
Journal:  Oncogene       Date:  2007-06-04       Impact factor: 9.867

8.  Intracellular retention of glycosylphosphatidyl inositol-linked proteins in caveolin-deficient cells.

Authors:  Federica Sotgia; Babak Razani; Gloria Bonuccelli; William Schubert; Michela Battista; Hyangkyu Lee; Franco Capozza; Ann Lane Schubert; Carlo Minetti; J Thomas Buckley; Michael P Lisanti
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

9.  MicroRNA-16 inhibits glioma cell growth and invasion through suppression of BCL2 and the nuclear factor-κB1/MMP9 signaling pathway.

Authors:  Tian-Quan Yang; Xiao-Jun Lu; Ting-Feng Wu; Da-Dong Ding; Zhao-Hui Zhao; Gui-Lin Chen; Xue-Shun Xie; Bin Li; Yong-Xin Wei; Ling-Chuan Guo; Yu Zhang; Yu-Lun Huang; You-Xin Zhou; Zi-Wei Du
Journal:  Cancer Sci       Date:  2014-02-11       Impact factor: 6.716

10.  MicroRNA-195 inhibits the proliferation of human glioma cells by directly targeting cyclin D1 and cyclin E1.

Authors:  Wang Hui; Lu Yuntao; Luo Lun; Li WenSheng; Liang ChaoFeng; He HaiYong; Ba Yueyang
Journal:  PLoS One       Date:  2013-01-28       Impact factor: 3.240

View more
  49 in total

Review 1.  MicroRNA as potential biomarkers in Glioblastoma.

Authors:  Zammam Areeb; Stanley S Stylli; Rachel Koldej; David S Ritchie; Tali Siegal; Andrew P Morokoff; Andrew H Kaye; Rodney B Luwor
Journal:  J Neurooncol       Date:  2015-09-21       Impact factor: 4.130

2.  Loss of miR-873 contributes to gemcitabine resistance in triple-negative breast cancer via targeting ZEB1.

Authors:  Gangyue Wang; Yi Dong; Heng Liu; Nan Ji; Jilei Cao; Aihui Liu; Xin Tang; Yu Ren
Journal:  Oncol Lett       Date:  2019-08-01       Impact factor: 2.967

3.  LINC01420 RNA structure and influence on cell physiology.

Authors:  Daria O Konina; Alexandra Yu Filatova; Mikhail Yu Skoblov
Journal:  BMC Genomics       Date:  2019-05-08       Impact factor: 3.969

4.  MicroRNAs-491-5p suppresses cell proliferation and invasion by inhibiting IGF2BP1 in non-small cell lung cancer.

Authors:  Fangchao Gong; Ping Ren; Yan Zhang; Jindong Jiang; Hong Zhang
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

5.  MicroRNA-873 mediates multidrug resistance in ovarian cancer cells by targeting ABCB1.

Authors:  Di-di Wu; Xue-Song Li; Xiao-Na Meng; Jing Yan; Zhi-Hong Zong
Journal:  Tumour Biol       Date:  2016-02-05

6.  IGF2BP1 overexpression causes fetal-like hemoglobin expression patterns in cultured human adult erythroblasts.

Authors:  Jaira F de Vasconcellos; Laxminath Tumburu; Colleen Byrnes; Y Terry Lee; Pauline C Xu; May Li; Antoinette Rabel; Benjamin A Clarke; Nicholas R Guydosh; Richard L Proia; Jeffery L Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-26       Impact factor: 11.205

7.  miR-372 suppresses tumour proliferation and invasion by targeting IGF2BP1 in renal cell carcinoma.

Authors:  Xuan Huang; Mingjie Huang; Lingbao Kong; Yong Li
Journal:  Cell Prolif       Date:  2015-10       Impact factor: 6.831

8.  miR-503 inhibits cell proliferation and invasion in glioma by targeting L1CAM.

Authors:  Hao Liu; Zhi Song; Daguang Liao; Tianyi Zhang; Feng Liu; Wen Zheng; Kui Luo; Liang Yang
Journal:  Int J Clin Exp Med       Date:  2015-10-15

Review 9.  PD-1/PD-L1 pathway: current researches in cancer.

Authors:  Yanyan Han; Dandan Liu; Lianhong Li
Journal:  Am J Cancer Res       Date:  2020-03-01       Impact factor: 6.166

10.  miR-873 induces lung adenocarcinoma cell proliferation and migration by targeting SRCIN1.

Authors:  Yushun Gao; Qi Xue; Dali Wang; Minjun Du; Yanjiao Zhang; Shugeng Gao
Journal:  Am J Transl Res       Date:  2015-11-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.